the American Association for Cancer Research
No mentions found
This entity hasn't been tracked yet, or Iris is still building its knowledge base.
Related Articles from SNS
One fat helped pancreatic cancer grow while another cut disease in half
One fat helped pancreatic cancer grow while another cut disease in half - Date: - June 2, 2026 - Source: - Yale School of Medicine - Summary: - A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how much. Researchers found that oleic acid—the main fat in olive oil and several other common foods—sped up tumor growth in mice predisposed to pancreatic cancer, while omega-3-rich fats from fish oil dramatically slowed disease...
Why cancer spreads more in middle age than in old age
Why cancer spreads more in middle age than in old age Melanoma may be most dangerous in middle age, as cancer briefly gains the upper hand against the immune system before losing it again in extreme old age. - Date: - May 31, 2026 - Source: - Temple University Health System - Summary: - Melanoma may not become steadily more dangerous with age as scientists once assumed. In a surprising discovery, researchers found that cancer spread was lowest in young mice, surged in middle-aged mice, and...
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk Popular GLP-1 weight-loss drugs may have an unexpected bonus: a significantly lower risk of breast cancer. - Date: - June 6, 2026 - Source: - University of Pennsylvania School of Medicine - Summary: - A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer.
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer
GLP-1 drugs, including Ozempic, may have a beneficial effect across many types of cancer More than two dozen studies suggest the treatments are linked to lower cancer risk, reduced metastasis and improved survival, though researchers say trials are needed to confirm any anti-cancer benefit. A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than two dozen studies presented over the...
Weight-loss drugs may cut breast cancer risk by up to 30%, study finds
Women on weight-loss medication may have a lower risk of developing breast cancer, according to a new study. Women who take GLP-1 medications, such as Ozempic or Mounjaro, are less likely to develop breast cancer, a new study has found. The findings, presented at the 2026 American Society of Clinical Oncology (ASCO) annual meeting, come from an analysis of more than 110,000 women aged between 45 and 80.
First ever guidelines released to screen for condition that impacts 9 in 10 Americans
First ever guidelines released to screen for condition that impacts 9 in 10 Americans Doctors say earlier screening could help save lives - Bookmark - CommentsGo to comments Some 90 percent of Americans have at least one risk factor for cardiovascular-kidney-metabolic – or CKM – syndrome, a term for potentially life-threatening conditions that are all connected. Now, experts at the American Heart Association say more of the country should be screened for one particular risk factor in the...
Disability, disease and death warning for anyone drinking alcohol
Disability, disease and death warning for anyone drinking alcohol A major new study has prompted an urgent 'danger' alert One glass of wine or pint of beer a day is enough to increase the risk of cancer and heart disease, warns new research. Even what most people consider a "moderate" or sensible level of alcohol intake "substantially" elevates the dangers of dying young, disability and chronic diseases, say scientists.
Republicans are trying to kill science in this country
Researchers say the Trump administration is finding new ways to punish science Standing in his laboratory, Harvard professor Sean Eddy gazes at a row of vacant work stations. More than a year ago, this lab was filled with over a dozen researchers. On a given day they might be working independently on analyzing genomic sequencing or gathered around the group table, drinking coffee and helping each other troubleshoot questions about genomic data from different species.
Study that was sidelined by Trump administration tells Americans to limit themselves to one drink per day
Study that was sidelined by Trump administration tells Americans to limit themselves to one drink per day Researchers commissioned by President Joe Biden's Democratic administration to investigate alcohol-related health harms have released their findings independently - Bookmark A significant study commissioned by the administration of President Joe Biden, investigating alcohol-related health harms, was independently released on Tuesday, after the administration of Donald Trump reportedly...
Cancer survivors may see surprising benefits from one specific exercise, study says
For many, surviving cancer comes with an automatic new lease on life but other survivors continue to experience physical and emotional challenges long after treatment ends. Yoga may significantly reduce the insomnia, fatigue and mood disturbances many survivors endure after remission, a recent clinical trial found. Mood disturbance and insomnia are "two of the most pervasive and troubling side effects experienced by cancer survivors for years after completing adjuvant treatments," the...